Literature DB >> 807734

Synthesis of a fluorescent derivative of amethopterin,.

G R Gapski, J M Whiteley, J I Rader, P L Cramer, G B Henderson, V Neef, F M Huennekens.   

Abstract

Fluorescein isothiocyanate was treated with excess diaminopentane and the remaining unsubstituted amino group of the product was condensed, via a carbodiimide-promoted reaction, with a carboxyl group of amethopterin. The final product, a fluorescent derivative of amethopterin, was isolated by chromatography on AE-cellulose and preparative electrophoresis on polyacrylamide. It was shown to be homogeneous by analytical polyacrylamide electrophoresis and thin-layer chromatography. Proof of structure was provided by elemental analysis, absorbance spectra (at pH 7.0, lambdamax at 495 nm; fluorescence emission at 520 nm), and 1H NMR measurements. The fluorescent derivative of amethopterin inhibited transport of amethopterin into Lactobacillus casei and L1210 cells. It was also a good inhibitor of the L. casei and L1210 dihydrofolate reductases and could be used to provide a fluorescent label for the enzymes during polyacrylamide electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807734     DOI: 10.1021/jm00239a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

2.  Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate.

Authors:  Seok Ki Choi; Thommey Thomas; Ming-Hsin Li; Alina Kotlyar; Ankur Desai; James R Baker
Journal:  Chem Commun (Camb)       Date:  2010-02-06       Impact factor: 6.222

3.  Simultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.

Authors:  Heike Glauner; Ivo R Ruttekolk; Kerrin Hansen; Ben Steemers; Yi-Da Chung; Frank Becker; Stefan Hannus; Roland Brock
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 4.  Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.

Authors:  H M Davey; D B Kell
Journal:  Microbiol Rev       Date:  1996-12

5.  Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry.

Authors:  Y G Assaraf; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  The use of a fluorescent methotrexate probe to monitor the effects of three vinca alkaloids on a mixed population of parental L1210 and gene-amplified methotrexate-resistant cells by flow cytometry.

Authors:  D G Poppitt; A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery.

Authors:  Thommey P Thomas; Seok Ki Choi; Ming-Hsin Li; Alina Kotlyar; James R Baker
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

8.  Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays.

Authors:  I Remy; S W Michnick
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Methods to evaluate the effect of ethanol on the folate analogue: fluorescein methotrexate uptake in human proximal tubular cells.

Authors:  Sivakumar Jt Gowder; Kenneth E McMartin
Journal:  Adv Pharmacol Sci       Date:  2009-09-29

10.  Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.

Authors:  D L Boring; X D Ji; J Zimmet; K E Taylor; G L Stiles; K A Jacobson
Journal:  Bioconjug Chem       Date:  1991 Mar-Apr       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.